Jodi Luchs, MD Carlos Buznego, MD William Trattler, MD

Slides:



Advertisements
Similar presentations
Incidence of Blepharitis in Patients Undergoing Phacoemulsification Jodi Luchs, MD Carlos Buznego, MD William Trattler, MD The authors of this poster have.
Advertisements

Are topical NSAIDs a safe and effective treatment for Corneal Abrasions? Department of Emergency Medicine University of Pennsylvania Health System Andrew.
Delay in Symptom Resolution After Thermal Pulsation System Treatment for Meibomian Gland Dysfunction in Dry-Eye Disease Delay in Symptom Resolution After.
Non-Invasive Keratograph Tear Break-Up Time versus Invasive Fluorescein-Associated Tear Stability Test: Experimental Validation Study Nizar S Abdelfattah,
Impact of Conjunctivochalasis in Dry Eye
Epitheliopathy in the Region of the Eyelid Associated with the Caruncle in Normal Subjects and Dry-Eye Patients Epitheliopathy in the Region of the Eyelid.
Yousef A Alghamdi, MD; Allison L McClellan, OD; Nabeel M Shalabi, MD Anat Galor, MD, MSPH Supported by the Department of Veterans Affairs, Veterans Health.
Lower Extremity Venous Disease: Peripheral Venous Insufficiency
W. B. Trattler; C. D. Reilly; D. F. Goldberg; P. A. Majmudar; J. A. Vukich; M. Packer; E. D. Donnenfeld.
® Introduction Mental Health Predictors of Pain and Function in Patients with Chronic Low Back Pain Olivia D. Lara, K. Ashok Kumar MD FRCS Sandra Burge,
Blepharitis and Dry eyes in Aromatase Inhibitor Users Kiran Turaka, M.D. Kristin M. Hammersmith, M.D. Jennifer M. Nottage, M.D. Christopher J. Rapuano,
Outcome of refractive surgery in keratoconus suspect eyes
Association between Depression And Dry eye Sang Beom Han, MD, 1 Joon Young Hyon, MD, 1 Young Joo Shin, MD, 1 Won Ryang Wee, MD, 2 Jin Hak Lee, MD, 1 1.
Blepharitis and Dry eyes in Aromatase Inhibitor Users
Bepotastine Besilate Ophthalmic Solution 1.5% and Degree of Reduced Ocular Itching in a Conjunctival Allergen Challenge Test JI Williams 1, G Torkildsen.
Effects of Xalatan® (latanoprost) or Travatan® (travoprost) on Ocular Surface Signs and Symptoms in Ocular Hypertensive or Glaucoma Patients. M.B. McDonald1,
Ocular Comfort Assessment of Bepotastine Besilate Ophthalmic Solution 1.5% in Multicenter Conjunctival Allergen Challenge Clinical Trial JA Gow 1, TT Macejko.
Integrated Trial Results of Bepotastine Besilate Ophthalmic Solution 1.5% on Eyelid Swelling in a Clinical Model of Allergic Conjunctivitis TR McNamara.
Correlation Between Corneal Biomechanics and Wavefront Aberrations Alejandro Rivera, MD Private Practice Mexico City The author has no financial interest.
ENESTnd Update: Nilotinib (NIL) vs Imatinib (IM) in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and the Impact.
Durezol™ (difluprednate ophthalmic emulsion) 0.05% BID or QID starting 1 day before cataract surgery for treatment of postoperative inflammation and pain.
Vision related quality of life in persons with Dry eye syndrome using the 25 item National eye Institute visual function questionnaire S.P. Mahesh MD Janine.
Blepharitis and Dry eyes in Aromatase Inhibitor Users Kiran Turaka, M.D. Kristin M. Hammersmith, M.D. Jennifer M. Nottage, M.D. Christopher J. Rapuano,
INTRODUCTION Upper respiratory tract infections, including acute pharyngitis, are common in general practice. Although the most common cause of pharyngitis.
Evaluation of Systane® versus Placebo in Corneal Epithelial Healing Following Photorefractive Keratectomy (PRK) Lt Col Charles D. Reilly Major Vasudha.
Topical Cyclosporine for Postoperative use in PRK and LASIK: Preliminary Results LCDR David D. Hessert, M.D. Ophthalmology Chief Resident Naval Medical.
Prospective Correlation of Symptoms and Clinical Grading in Vernal Keratoconjunctivitis Patients Srikant K Sahu, Shraddha Pawan Sureka, Sujata Das, Apurva.
Cole Eye Institute, Cleveland Clinic Foundation,
Intraductal Meibomian Gland Probing for Meibomian Gland Dysfunction Using VAS Testing (updated ) DISCLOSURE: Patent Pending Class One Device Made.
David R. Hardten 1, Mark Milner 2, Jai G. Parekh 3, Neda Shamie 4, Darrell E. White 5 and Michael Schiewe 6 Financial Disclosures: Dr’s Hardten, Milner,
Pattern of Pain and Analgesic use after Collagen Crosslinking for Progressive Keratoconus Ramon Coral Ghanem, MD, PhD. Renan Ferreira Oliveira, MD. Vinicius.
Prevalence of Dry Eye Disease among Elderly Korean Population Sang Beom Han, MD, 1 Joon Young Hyon, MD, 1 Won Ryang Wee, MD, 2,3 Jin Hak Lee, MD, 1, 3.
Safety and efficacy of bromfenac ophthalmic solution 0.09% (Xibrom™) compared to prednisolone acetate 1% for treatment of ocular inflammation following.
Mean Keratometry Measurement Post Penetrating Keratoplasty Jacky Yeung MSc MD, Stephanie Baxter MD FRCS(C) Department of Ophthalmology, Hotel Dieu Hospital,
Deep Anterior Lamellar Keratoplasty (DALK) Vs Penetrating Keratoplasty (PK) in patients with Keratoconus (KC). Dr. K.S.SIDDHARTHAN Aravind Eye Hospital.
Comparison of Efficacy of 0.05% Cyclosporine Ophthalmic Emulsion
Effect of Refractive State on Selective Laser Trabeculoplasty ASCRS 2011 Kevin Lai Stony Brook University School of Medicine Elaine M. Miglino Floral Park.
Efficacy of Topical Azithromycin & Cyclosporine A(CsA) vs CsA Alone in the Treatment of Dry Eyes Associated with Blepharitis Kenneth A. Beckman, M.D.,
Poster produced by Faculty & Curriculum Support (FACS), Georgetown University School of Medicine LASIK Combined with Corneal Cross-linking in Eyes with.
Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;
Shubhangi Arora1; Eden Haverfield2; Gabriele Richard2; Susanne B
The effects of Nd:YAG (neodymium: yttrium-aluminum-garnet) laser peripheral iridotomy (PI) on contra-lateral eye anterior chamber parameters of patients.
Department of Ophthalmology, University of Ulsan College of Medicine,
EVALUATION OF OCULAR SURFACE DISEASE IN PATIENTS AFTER TRABECULECTOMY: COMPARATIVE STUDY WITH AND WITHOUT INTRACAMERAL BEVACIZUMAB Sónia Parreira; Sandra.
In the Name of GOD.
Late In-the-bag Intraocular Lens Dislocation:
Prevalence of Symptomatic Dry Eye Disease in an Urban Chinese Community: A Cross-sectional Population-based Study Venice SW LI, Sophie SL YEOW, Jeffrey.
Prevalence of osteoarthritis after conservative versus reconstructive treatment of anterior cruciate ligament rupture. D. Tsoukas V.Ch. Fotopoulos Orthopaedic.
Effect of Selective Laser Trabeculoplasty on
Is Non-operative Treatment of Inguinal Hernias a Reasonable Option?
Risk of post-operative stroke in patients with known extra-cranial carotid artery disease undergoing Non-Cardiac Surgery Heart and Vascular.
Dr. James A. Davies, M.D. is the Medical Director of Davies Eye Center and The Surgical Eye Care Center. As a surgical pioneer, Dr. Davies has been recognized.
EEG characteristics & yield in evaluation of first non-febrile seizure in children in Qatar Abdulhafeez M Khair, Khalid Ibrahim, Rana Alshami, Ahmed Veten,
A Randomised Cross Over Comparison of Trehalose/Hyaluronate Eye Drops and Standard Treatment: Patient Satisfaction in the Treatment of Dry Eye Syndrome.
Volume 119, Issue 10, Pages (October 2012)
A presentation to: Meeting name Date
Conjunctival Impression Cytology in healthy volunteers
Rhematoid Rthritis Respiratory disorders
The authors have no financial interest
Eric Dai MD, Pawan Prasher MD, James McCulley MD, R. Wayne Bowman MD.
Associate Professor of Ophthalmology
Sirel G. Güngör, MD Cem Küçükerdönmez, MD Yonca A. Akova, MD
Yumiko Ban,1,2,3) Seika Den,2) Jun Shimazaki,2,3)
Role of HSV Infection in the Histopathology of Failed DSAEK
Winthrop University Hospital
Provider comparison reveals no difference between training levels
JAMA Ophthalmology Journal Club Slides: Effects of Azithromycin in Patients With Meibomian Gland Disease Zhang L, Su Z, Zhang Z, Lin J, Li D-Q, Pflugfelder.
The Effect of Corneal Thickness on Ocular Drug Penetration
I-Chan Lin MD, Paul P. Lee MD, JD
Floral Park Ophthalmology Winthrop University Hospital
Presentation transcript:

Jodi Luchs, MD Carlos Buznego, MD William Trattler, MD Asymptomatic or Minimally Symptomatic Blepharitis in Patients Having Cataract Surgery Jodi Luchs, MD Carlos Buznego, MD William Trattler, MD The authors of this poster have received research funding and travel expense reimbursement from Inspire Pharmaceuticals. Jodi Luchs, MD , Carlos Buznego, MD and William Trattler, MD are consultants for Inspire Pharmaceuticals.

Abstract Title: Asymptomatic or Minimally Symptomatic Blepharitis in Patients Having Cataract Surgery Authors: Jodi I. Luchs, Carlos Buznego, William B. Trattler Purpose: This sub-analysis of previously reported data analyzed the prevalence of asymptomatic or minimally symptomatic blepharitis and the tear film status in patients preparing to undergo cataract surgery. Methods: A sub-analysis of our previously reported cohort of 100 Patients was performed to assess the prevalence of minimally or asymptomatic blepharitis (mean symptom score or 1 or 0), and the tear film break-up time (TFBUT) in those patients. Results: 59/100 (59%) of patients had blepharitis. 45 of the 100 patients (45%) were asymptomatic or minimally symptomatic for ocular surface disease (mean symptom scores or 0 or 1), 26 of which had blepharitis (44.1%). 15/45(33.3%) of these patients had TFBUT scores of ≤5 seconds in at least one eye. Of these, 12 of the 15(80%) had blepharitis. Similarly, 31/45(68.9%) had TFBUT scores of ≤7 seconds in at least one eye. Of these, 19 of the 31 (61.3%) had blepharitis. 19/ 26 patients (73.0%) with minimally or asymptomatic blepharitis had TFBUT of 7 seconds or less. Conclusion: This sub-analysis reveals that minimally symptomatic/asymptomatic blepharitis is common in patients undergoing cataract surgery. The mild or absent symptoms may contribute to the condition being overlooked. However, this condition may have important effects on the TFBUT/ocular surface, which may have important pre/post-operative implications for patients undergoing ocular surgery.

Introduction Both Anterior and posterior blepharitis are common ocular surface disorders, which may be frequently overlooked, yet may have a significant impact on the outcomes of ocular surgery. Our previously reported data1 suggests that there is a high prevalence of blepharitis in patients preparing to undergo cataract surgery, yet the average clinical sign and symptom scores were mild-moderate. This sub-analysis evaluated the prevalence of minimally symptomatic or asymptomatic blepharitis and the status of the tear film in patients undergoing routine cataract surgery.

Methods A sub-analysis of data from a previously performed prospective, multicenter observational study which assessed the incidence of blepharitis in 100 patients scheduled to undergo cataract surgery was performed1. Minimally symptomatic patients were defined as those with a mean clinical symptom score of 1 (scale 0-4) Asymptomatic patients were defined as those with a symptom score of 0 Primary outcome measures in the original study: The presence or absence of blepharitis (presence of at least 2 clinical signs of blepharitis, at least one of which had a severity score of ≥2 on a scale of 0-4) Total blepharitis symptom severity score (summed symptom scores for itch, foreign body sensation, dryness, burning or pain, and swollen/heavy eyelids (scale 0-4 for each symptom)) Blepharitis clinical sign severity scores for lid debris, lid swelling, meibomian gland plugging, and quality of meibomian gland secretions (scale 0-4) Degree of ocular surface fluorescein staining (NEI grading system1) Tear film break up time (TFBUT)

Patient Demographics 59% of patients were diagnosed with blepharitis Mean age was 72.4 years (range: 52-88)

Prevalence of Blepharitis in the Study Population

Prevalence of Blepharitis in Symptomatic and Min/Asymptomatic Subjects

TFBUT Distribution of Asymptomatic/Minimally Symptomatic Subjects

Rapid TFBUT (≤ 7 Seconds) in Symptomatic and Min/Asymptomatic Blepharitis Subjects

Discussion Blepharitis is one of the most common conditions encountered by eye care professionals, although it may be frequently overlooked. It is important to recognize and treat this condition pre-operatively in patients about to undergo ocular surgery in order to potentially reduce the risk of post-operative infection,3-5 as well as to stabilize the tear film in order to ensure accurate pre-operative keratometry, topography or wavefront analysis. Post-operatively, untreated posterior blepharitis may also contribute to worsening of post-operative dry eye, fluctuating vision or a slower recovery of vision. Our original study found that 59% of patients undergoing routine evaluation for cataract surgery had clinical signs of blepharitis, making it a commonly occurring condition. However, the overall clinical sign and symptom scores were low for this cohort of patients, suggesting that this condition may be frequently overlooked. In this sub-analysis, we determined that almost half (45%) of the patients in the original study were asymptomatic or minimally symptomatic for ocular surface disease, yet more than half of those patients (26 of 45, 57.8%) had blepharitis. Conversely, of the 59% of patients who had blepharitis in this study, almost half (26 of 59, 44.1%) had minimal or no symptoms. However, there is a real disturbance to the tear film, even in these patients with minimal or no symptoms. One third of patients with minimal or no symptoms (15 of 45, 33.3%) had a TFBUT of 5 seconds or less in at least one eye. Of these, 12 of the 15 (80%) had blepharitis. Similarly, 68.9% of patients with little or no symptoms had a TFBUT of ≤ 7 seconds in at least one eye, and most of these patients (61.3%) also had blepharitis. Of the 26 patients with minimally or asymptomatic blepharitis, 73% had a TFBUT of ≤ 7 seconds. This suggests an association between the presence of blepharitis and a disturbance of the tear film, even in the presence of little or no symptoms. This may have important implications for patients undergoing ocular surgery. It should be noted that this observational study did not control for the presence of other ocular surface diseases such as dry eye in either group, which might confound these results.

Conclusions Blepharitis is common in patients preparing to undergo cataract surgery. Mild or absent symptoms may contribute to the condition being frequently overlooked. However, there is a real disturbance of the ocular surface as evidenced by the more rapid TFBUT in these minimally symptomatic or asymptomatic patients. This can have potentially important implications for pre-operative measurements and post-operative outcomes of cataract and refractive surgery. REFERENCES: 1Luchs JI, Buznego C, Trattler W: Prevalence of Blepharitis in Patients Scheduled for Routine Cataract Surgery. Poster presented at the American Society of Cataract and Refractive Surgery annual meeting, Boston, MA 2010 2Lemp MA. Report of National Eye Institute/Industry Work shop on clinical trials in dry eyes. C L A O J 1995;21:221-232 3EVS Study Group: Arch Ophthalmol 1995;113(12):1479-1496 4Solomon et. al.: J Cataract Refract Surg. 2003;29:2001-2006 5Speaker MG et al.: Ophthalmology 1991;98(5):639-649